Global Health Dermatology
About This Program
Our Dual Mission
- To improve diagnosis and treatment of skin conditions in resource-poor settings
- To train providers at home and abroad in delivering high-quality dermatologic care to those most in need
Who We Are
Dr. Esther Freeman, MD, PhD is Director of Global Health Dermatology at Massachusetts General Hospital, Harvard Medical School. She is Chair of the Clinical Guidelines Committee at the American Academy of Dermatology (AAD), and a member of the AAD's Task Force on Covid-19.
She has worked to improve healthcare, especially those affected by HIV, in sub-Saharan Africa, Latin America, and southeast Asia since 2003. She has collaborated with the World Health Organization since 2011, to establish guidelines for the treatment of HIV-associated skin conditions in the developing world. Her work centers around HIV-associated skin disease and HIV- associated cancer.
In 2020, Dr Freeman is overseeing the international Dermatology Covid-19 Registry in collaboration with the American Academy of Dermatology. Her work on Covid-19 has been featured in the New York Times and the Washington Post.
Where We Collaborate
Kenya: Moi Teaching and Referral Hospital, Eldoret, Kenya
Uganda: Infectious Disease Institute, Kampala, Uganda
Uganda: Mbarara Regional Referral Hospital, Mbarara, Uganda
Nigeria: Institute of Human Virology, Abuja, Nigeria
Switzerland: World Health Organization, Geneva, Switzerland
South Africa: Stellenbosch University, Tygerberg, South Africa
Learn More About What We Do
Dermatology is expanding its role globally by creating awareness of the disparities in care globally and by training healthcare workers in underserved areas to help improve healthcare, especially those patients affected by HIV.
Links to Our Work
COVID Related Issues
New York Times
International Dermatology & COVID-19 Registry
American Academy of Dermatology
Very Well Health
New York Times